UFC lightweight Gleison Tibau (pictured) was issued a provisional suspension by the USADA Friday.
Very little information was released regarding the potential doping violation, but the 32-year-old is facing at least a two-year ban.
“The U.S. Anti-Doping Agency (USADA) has notified both Gleison Tibau and UFC that he has been provisionally suspended due to a potential Anti-Doping Policy violation stemming from an out-of-competition test,” the UFC expressed in a statement. “USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Gleison Tibau. Additional information will be provided at the appropriate time in the process.”
Tibau was seen last month submitting Abel Trujillo at UFC Fight Night 77. If Tibau’s failed drug screening was connected to his fight with Trujillo, which is likely the case given the timing, the bout will be overturned to a no contest.
This marks Tibau’s first flunked drug test in his 16-year professional career.
The USADA officially kicked off their partnership with the UFC on July 1 to randomly drug test its fighters year-round for performance-enhancing drugs. The UFC parlayed their anti-PED movement by enforcing stricter punishments for cheaters.
Under the new policy, first-time offenders for performance-enhancing drug will receive a two-year ban, four years with “aggravating circumstance.” The suspension is doubled for the second offense and double of the second penalty on the third offense.
Marijuana and other recreational drugs will only be tested in-competition. These failed screenings will result in a one-year suspension, two years for aggravating circumstance. The suspension is doubled for the second offense and double of the second penalty on the third offense.